Novozymes A-S (B) Aktie
49,53
EUR
-1,39
EUR
-2,73
%
49,37
EUR
-1,41
EUR
-2,78
%
Werbung
Novozymes A-S (B) Aktie Analyse
| 03.09.12 | Novozymes A-S (B) buy | ING | |
| 28.08.12 | Novozymes A-S (B) overweight | Morgan Stanley | |
| 09.08.12 | Novozymes A-S (B) overweight | Morgan Stanley | |
| 19.06.12 | Novozymes A-S (B) overweight | Morgan Stanley | |
| 17.11.11 | Novozymes A-S (B) overweight | Morgan Stanley |
Werbung
Werbung